SCHEMBL4440941

SCHEMBL4440941

COc1ccccc1Cc1nc2cccc(C(N)=O)c2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.46
CHEK2 O96017 2/20 0.45
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
PARP14 Q460N5 1/20 0.43
PARP10 Q53GL7 1/20 0.43
PNP P00491 1/20 0.42
CDK9 P50750 1/20 0.41
DYRK1A Q13627 1/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 2/20 0.41
TSHR P16473 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
NR3C2 P08235 1/20 0.41
MAPK8 P45983 1/20 0.41
MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7363580 0.85 RAB9A (0.60) PARP1CDK9DYRK1ANPC1RAB9A
SCHEMBL7363561 0.79 PLK4 (0.42) PARP1AURKANPC1RAB9ASMN1; SMN2
SCHEMBL403922 0.77 POLB (0.49) CDK9DYRK1APOLBSMN1; SMN2LMNA
SCHEMBL8648025 0.77 PARP1 (0.67) PARP1CHEK2CDK9DYRK1A
SCHEMBL4235282 0.77 HPGD (0.58) NPC1LMNAHTTMEN1MAPT
SCHEMBL14347043 0.77 DDAH1 (0.46) PARP1AURKAMAPK1ALOX15HSD17B10
SCHEMBL11480595 0.76 CHEK2 (0.46) PARP1CHEK2PARP14PARP10PNP
SCHEMBL28348830 0.76 HPGD (0.50) AURKARPS6KB1PARP14PARP10NPC1
SCHEMBL7369651 0.75 RAB9A (0.56) PARP1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL15540355 0.75 HPGD (0.53) AURKARPS6KB1PARP14PARP10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125753-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed
WO-2008082003-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-10 WO disclosed